Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 15968457)

1.

Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Bové J, Serrats J, Mengod G, Cortés R, Tolosa E, Marin C.

Exp Brain Res. 2005 Sep;165(3):362-74. Epub 2005 Jun 21.

PMID:
15968457
2.

Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior.

Steiner H, Gerfen CR.

Exp Brain Res. 1998 Nov;123(1-2):60-76. Review.

PMID:
9835393
3.

Adenosine A2A receptors and basal ganglia physiology.

Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S.

Prog Neurobiol. 2007 Dec;83(5):277-92. Epub 2007 Jun 26. Review.

4.

New synaptic and molecular targets for neuroprotection in Parkinson's disease.

Calabresi P, Di Filippo M, Gallina A, Wang Y, Stankowski JN, Picconi B, Dawson VL, Dawson TM.

Mov Disord. 2013 Jan;28(1):51-60. doi: 10.1002/mds.25096. Epub 2012 Aug 23. Review.

5.

Targeting adenosine A2A receptors in Parkinson's disease.

Schwarzschild MA, Agnati L, Fuxe K, Chen JF, Morelli M.

Trends Neurosci. 2006 Nov;29(11):647-54. Epub 2006 Oct 9. Review.

PMID:
17030429
6.

Pathophysiological roles for purines: adenosine, caffeine and urate.

Morelli M, Carta AR, Kachroo A, Schwarzschild MA.

Prog Brain Res. 2010;183:183-208. doi: 10.1016/S0079-6123(10)83010-9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk